VIPERFAV perfusive solution concentrate medication leaflet

J06BB antivenom • Antiinfectives for systemic use | Immunoglobulins | Specific immunoglobulins

Antivenom serum is a product derived from the plasma of animals (usually horses) immunized against viper venom. It is used to treat viper bites by neutralizing the toxic effects of the venom and preventing severe complications such as kidney failure, coagulopathy, shock, or tissue necrosis.

The antivenom serum is administered intravenously, typically in specialized medical facilities, under strict medical supervision. The dosage is determined based on the severity of the envenomation, the patient's symptoms, and the specific type of viper involved.

Side effects may include allergic reactions such as skin rashes, itching, fever, or, in rare cases, anaphylactic reactions. Serum sickness, a delayed reaction characterized by fever, joint pain, and skin rashes, may also occur days or weeks after administration.

Antivenom serum is a life-saving treatment in cases of severe envenomation, but its use requires careful monitoring to manage potential adverse effects. It is crucial for patients to seek immediate medical attention after a viper bite, and the serum should only be administered by qualified medical personnel.

General data about VIPERFAV

Substance: antivenom

Commercial code: W66066001

Pharmaceutical form: perfusive solution concentrate

Packing volume: 4ml

Product type: generic

Prescription restrictions: S - Medicines prescription reserved for use in certain specialized fields.

Marketing authorisation

Manufacturer: SANOFI PASTEUR - FRANTA

Holder: C.N. UNIFARM S.A. - ROMANIA

Number: 432/2019/01

Shelf life: 2 years

Pharmaceutical forms available for antivenom

Concentrations available for antivenom

500 UA/fiola, 500UA LD50/fiola